Literature DB >> 3891968

Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes.

H Satoh, Y Fukuda, D K Anderson, V J Ferrans, J R Gillette, L R Pohl.   

Abstract

The fulminant hepatotoxicity caused by halothane has been thought to have an immunological basis because this toxicity occurs most often after repeated administration of halothane and because sera from patients recovering from severe halothane hepatotoxicity contain antibodies that bind to the surface membranes of hepatocytes of rabbits treated with halothane. In order to determine whether the major reactive metabolite of halothane, trifluoroacetyl halide, covalently binds to hepatocytes, we have developed specific and sensitive peroxidase enzyme-linked immunosorbent assays and an indirect immunofluorescence staining method for identifying trifluoroacetylated (TFA)-hepatocytes. Liver sections prepared from rats at 4 hr after halothane administration were stained preferentially in the centrilobular region with anti-TFA serum whereas livers of control rats showed no staining. The specificity of the assay for the TFA group was confirmed by the complete inhibition of the staining with 200 microM N-epsilon-TFA-L-lysine in the diluted antiserum. On the other hand, 2 mM halothane or L-lysine did not inhibit this staining. Moreover, treatment of rats with deuterated halothane resulted in significantly less staining than did halothane. At 24 hr after halothane administration, hepatocytes isolated and stained by indirect immunofluorescence showed a linear and granular pattern on their surface membranes. These results indicate that trifluoroacetyl halide either reacts directly with constituents of the plasma membranes or with other cellular components which become incorporated into the plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891968

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

Review 1.  Protein damage by reactive electrophiles: targets and consequences.

Authors:  Daniel C Liebler
Journal:  Chem Res Toxicol       Date:  2007-12-04       Impact factor: 3.739

Review 2.  Immunotoxic side-effects of drug therapy.

Authors:  J A Mitchell; E M Gillam; L A Stanley; E Sim
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

3.  Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

Authors:  H Satoh; B M Martin; A H Schulick; D D Christ; J G Kenna; L R Pohl
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Reactive intermediates: molecular and MS-based approaches to assess the functional significance of chemical-protein adducts.

Authors:  Terrence J Monks; Serrine S Lau
Journal:  Toxicol Pathol       Date:  2012-12-06       Impact factor: 1.902

5.  Characterization of a halothane-induced humoral immune response in rabbits.

Authors:  A H Callis; S D Brooks; T P Roth; A J Gandolfi; B R Brown
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

6.  Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

Authors:  M A Robin; M Maratrat; M Le Roy; F P Le Breton; E Bonierbale; P Dansette; F Ballet; D Mansuy; D Pessayre
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 7.  Clinical pharmacokinetics of the inhalational anaesthetics.

Authors:  O Dale; B R Brown
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

8.  Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.

Authors:  P Beaune; P M Dansette; D Mansuy; L Kiffel; M Finck; C Amar; J P Leroux; J C Homberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.

Authors:  Y Sakaguchi; S Inaba; K Irita; H Sakai; H Nawata; S Takahashi
Journal:  Can J Anaesth       Date:  1994-05       Impact factor: 5.063

10.  Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.

Authors:  N R Kitteringham; J G Kenna; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.